Melanoma chemoprevention: a role for statins or fibrates?

American Journal of Therapeutics
Robert P DellavalleLisa M Schilling

Abstract

Although numerous second-generation isoprenylation inhibitors are proposed or under investigation for the treatment and/or prevention of cancer (eg, R115777, SCH 66336, L-778,123, BMS-214662), the chemotherapeutic and chemopreventive potential of commonly prescribed first-generation isoprenylation inhibitors, the statins, and other classes of lipid-lowering medications, the fibrates, has yet to be seriously explored. Two lipid-lowering medications, lovastatin and gemfibrozil, have been associated with a decreased incidence of melanoma in large, prospective, randomized, double-blind, placebo-controlled clinical cardiology trials. This article reviews melanoma biology and the clinical evidence for the use of lipid-lowering medications for melanoma chemoprevention and/or adjuvant chemotherapy.

References

Dec 15, 1991·Annals of Internal Medicine·M H Criqui
Aug 11, 1990·BMJ : British Medical Journal·M F MuldoonK A Matthews
Aug 1, 1990·Journal of the American Academy of Dermatology·V A AlbertR A Lew
Sep 10, 1988·BMJ : British Medical Journal·A J SwerdlowD J Hole
Jan 1, 1987·Epidemiologic Reviews·S Greenland
Mar 15, 1980·International Journal of Cancer. Journal International Du Cancer·C D HolmanB K Armstrong
Dec 1, 1993·Melanoma Research·B K Armstrong, A Kricker
Aug 1, 1996·British Journal of Cancer·A J VersluisM K Bijsterbosch
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M FormanR M Evans
May 20, 1998·Journal of the American Academy of Dermatology·H TsaoA J Sober
May 20, 1998·Journal of the American Academy of Dermatology·T M JohnsonL Lowe
Jun 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W FeleszkoM Jakóbisiak
Aug 7, 1998·Dermatology : International Journal for Clinical and Investigative Dermatology·L ThomasG Moulin
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Dec 18, 1998·American Journal of Clinical Oncology·J LarnerM Shaffrey
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J E GershenwaldM I Ross
Apr 29, 1999·The New England Journal of Medicine·B A GilchrestM Yaar
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E K RowinskyD D Von Hoff
Jan 5, 2000·The Journal of Clinical Investigation·J B Gibbs
Feb 25, 2000·Journal of the American Academy of Dermatology·P WalshR Gonzalez
Apr 25, 2000·Journal of the American Academy of Dermatology·M Piepkorn
May 20, 2000·Advances in Cancer Research·N BardeesyL Chin
Jun 24, 2000·JAMA : the Journal of the American Medical Association·C R MeierH Jick
Jun 24, 2000·JAMA : the Journal of the American Medical Association·P S WangJ Avorn
Jul 7, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S P StrattonD S Alberts
Aug 11, 2000·JAMA : the Journal of the American Medical Association·M A Weinstock
Aug 22, 2000·The Journal of Investigative Dermatology·L G KömüvesK R Feingold

❮ Previous
Next ❯

Citations

Jul 28, 2004·Archives of Dermatological Research·Maja GrabackaAndrzej Slominski
Aug 5, 2004·Current Oncology Reports·Marie-France Demierre, Glenn Merlino
May 12, 2005·Urologic Oncology·Mark A Moyad, Gregory S Merrick
Jan 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Dipak PanigrahyMark W Kieran
Nov 2, 2006·Journal of the National Cancer Institute·Scott R FreemanRobert P Dellavalle
Jul 21, 2005·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Claudia C RamirezRobert S Kirsner
Aug 22, 2009·Immunopharmacology and Immunotoxicology·Avik Roy, Kalipada Pahan
Mar 14, 2007·Mayo Clinic Proceedings·Svetomir N MarkovicUNKNOWN Melanoma Study Group of the Mayo Clinic Cancer Center
Feb 19, 2005·Critical Reviews in Oncology/hematology·Marie-France Demierre, Vernon K Sondak
Oct 21, 2006·Journal of the American Academy of Dermatology·Shayla O FrancisRobert P Dellavalle
May 11, 2010·Biochemical Pharmacology·Gajanan S InamdarGavin P Robertson
Apr 10, 2007·Mayo Clinic Proceedings·Svetomir N MarkovicUNKNOWN Melanoma Study Group of Mayo Clinic Cancer Center
Mar 16, 2017·Photochemistry and Photobiology·Gagan ChhabraNihal Ahmad
Jan 1, 2010·Cancers·Ryan G GambleRobert P Dellavalle
Dec 13, 2005·Nature Reviews. Cancer·Marie-France DemierreScott M Lippman
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Delia Di StasiMonica Rodolfo
Oct 20, 2005·The Cochrane Database of Systematic Reviews·R P DellavalleL Schilling
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maja GrabackaKrzysztof Reiss
Apr 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Frank L MeyskensHoda Anton-Culver
Jan 12, 2010·Cellular Signalling·Nayana Ghosh-ChoudhuryGoutam Ghosh Choudhury

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
K H Kraemer
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
A DupuyF de Vathaire
Cancer Treatment Reviews
Y D PodnosR J Barr
Journal of the American Academy of Dermatology
I N Botev
© 2022 Meta ULC. All rights reserved